These do not influence our content moderation policies in any way, though ProductReview.com.au may earn commissions for products/services purchased via affiliate links.
We ensure that the necessary documentation is submitted, helping patients receive the medications they need for effective weight management and diabetes care
Most patients begin noticing some weight loss within the first few weeks of starting a GLP-1 agonist, especially as the dose is gradually increased to the optimal maintenance level
Better results, fewer side effects
There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial
doi: 10.3389/fphar.2026.1754721 Received 26 November 2025 Revised 28 February 2026 Accepted 03 March 2026 Published 19 March 2026 Volume 17 - 2026 Edited by Achuthan Raghavamenon, Amala Cancer Research Centre, India Reviewed by Abdul Rahim Chethikkattuveli Salih, Terasaki Institute for Biomedical Innovation, United States Julio Plaza-Diaz, Childrens Hospital of Eastern Ontario (CHEO), Canada Updates Copyright 2026 Hu, Tian, Yang, Zhang, Zhang, Xu and Lu
